{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3,3\u2032-Diindolylmethane", "Adjunctive therapy", "Cancer immunotherapy", "Myeloid-derived suppressor cells", "PD-1 blockade"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35773674", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "30"}], "Language": ["eng"], "ELocationID": ["81", "10.1186/s13020-022-00638-z"], "Journal": {"ISSN": "1749-8546", "JournalIssue": {"Volume": "17", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "30"}}, "Title": "Chinese medicine", "ISOAbbreviation": "Chin Med"}, "ArticleTitle": "3,3'-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells.", "Pagination": {"StartPage": "81", "MedlinePgn": "81"}, "Abstract": {"AbstractText": ["Immune checkpoint inhibitors that target programmed cell death protein 1 (PD-1) have obtained encouraging results, but a fraction of tumor patients failed to respond to anti-PD-1 treatment due to the existence of multiple immune suppressive elements such as myeloid-derived suppressor cells (MDSCs). Traditional Chinese medicine or natural products from medicinal plants could enhance immunity and may be helpful for cancer immunotherapy. As a digestive metabolite from cruciferous plants, 3,3'-diindolylmethane (DIM) has been widely used in chemotherapy, but its influence on cancer immunotherapy remains unclear. Here we investigate the function of DIM on MDSCs and examine the therapeutic effects of DIM in conjunction with PD-1 antibody against mouse tumors.", "Flow cytometry analysis, Western blot analysis and qRT-PCR assay were used to examine the inhibitory effects and mechanisms of DIM on MDSCs in vitro and in vivo. The therapeutic effects of DIM on cancer immunotherapy by PD-1 antibody were evaluated in mouse models of breast cancer and melanoma tumor.", "DIM exerted the inhibitory effect on MDSCs via downregulating miR-21 level and subsequently activating PTEN/PIAS3-STAT3 pathways. Adoptive transfer of MDSCs impaired the therapeutic effects of DIM, indicating that the antitumor activity of DIM might be due to the suppression of MDSCs. Furthermore, in mouse models of breast cancer and melanoma tumor, the addition of DIM can enhance the therapeutic effect of PD-1 antibody through promoting T cells responses, and thereby inhibiting tumor growth.", "Overall, the strategy based on the combination treatment of anti-PD-1 antibody and DIM may provide a new approach for cancer immunotherapy. Cruciferae plants-rich diet which contains high amount of DIM precursor may be beneficial for cancer patients that undergo the anti-PD-1 treatment."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China."}], "LastName": "Sun", "ForeName": "Qi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China."}], "LastName": "Xiao", "ForeName": "Lin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China."}], "LastName": "Cui", "ForeName": "Zhiying", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China."}], "LastName": "Yang", "ForeName": "Yaping", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China. majunting@ahmu.edu.cn."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, 230032, Hefei, China. majunting@ahmu.edu.cn."}], "LastName": "Ma", "ForeName": "Junting", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China. zhenhuang@nju.edu.cn."}], "LastName": "Huang", "ForeName": "Zhen", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China."}], "LastName": "Zhang", "ForeName": "Junfeng", "Initials": "J"}, {"Identifier": ["0000-0001-9380-8284"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Analytical Chemistry for Life Sciences and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 210023, Nanjing, China. jnchen@nju.edu.cn."}], "LastName": "Chen", "ForeName": "Jiangning", "Initials": "J"}], "GrantList": [{"GrantID": "31870821", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "31771550", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "81972267", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "81673380", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "81973273", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "31571458", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "020814380145", "Agency": "Fundamental Research Funds for the Central Universities", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Chin Med", "NlmUniqueID": "101265109", "ISSNLinking": "1749-8546"}, "CoiStatement": "No potential conflicts of interest were disclosed."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Taylor A, Rothstein D, Rudd CE. Small-molecule inhibition of PD-1 transcription is an effective alternative to antibody blockade in cancer therapy. Cancer Res. 2018;78(3):706\u201317. doi: 10.1158/0008-5472.CAN-17-0491.", "ArticleIdList": ["10.1158/0008-5472.CAN-17-0491", "29055015"]}, {"Citation": "Binder DC, Schreiber H. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res. 2013;73(12):3591\u2013603. doi: 10.1158/0008-5472.CAN-12-4100.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-4100", "PMC3686913", "23633484"]}, {"Citation": "Kaneda MM, Messer KS, Ralainirina N, et al. PI3Kgamma is a molecular switch that controls immune suppression. Nature. 2016;539(7629):437\u201342. doi: 10.1038/nature19834.", "ArticleIdList": ["10.1038/nature19834", "PMC5479689", "27642729"]}, {"Citation": "Limagne E, Richard C, Thibaudin M, et al. Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients. Oncoimmunology. 2019;8(4):e1564505. doi: 10.1080/2162402X.2018.1564505.", "ArticleIdList": ["10.1080/2162402X.2018.1564505", "PMC6422400", "30906658"]}, {"Citation": "Saleh R, Elkord E. Treg-mediated acquired resistance to immune checkpoint inhibitors. Cancer Lett. 2019;457:168\u201379. doi: 10.1016/j.canlet.2019.05.003.", "ArticleIdList": ["10.1016/j.canlet.2019.05.003", "31078738"]}, {"Citation": "Theivanthiran B, Evans KS, DeVito NC, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J Clin Invest. 2020;130(5):2570\u201386. doi: 10.1172/JCI133055.", "ArticleIdList": ["10.1172/JCI133055", "PMC7190922", "32017708"]}, {"Citation": "Tesi RJ. The most important cell you have never heard of\u00a0MDSC. Trends Pharmacol Sci. 2019;40(1):4\u20137. doi: 10.1016/j.tips.2018.10.008.", "ArticleIdList": ["10.1016/j.tips.2018.10.008", "30527590"]}, {"Citation": "Kumar V, Patel S, Tcyganov E, et al. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 2016;37(3):208\u201320. doi: 10.1016/j.it.2016.01.004.", "ArticleIdList": ["10.1016/j.it.2016.01.004", "PMC4775398", "26858199"]}, {"Citation": "Kim K, Skora AD, Li Z, et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc Natl Acad Sci U S A. 2014;111(32):11774\u20139. doi: 10.1073/pnas.1410626111.", "ArticleIdList": ["10.1073/pnas.1410626111", "PMC4136565", "25071169"]}, {"Citation": "Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. 2015;125(9):3356\u201364. doi: 10.1172/JCI80005.", "ArticleIdList": ["10.1172/JCI80005", "PMC4588239", "26168215"]}, {"Citation": "Smyth MJ, Ngiow SF, Ribas A, Teng MW. Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol. 2016;13(3):143\u201358. doi: 10.1038/nrclinonc.2015.209.", "ArticleIdList": ["10.1038/nrclinonc.2015.209", "26598942"]}, {"Citation": "Yu SJ, Ma C, Heinrich B, et al. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. J Hepatol. 2019;70(3):449\u201357. doi: 10.1016/j.jhep.2018.10.040.", "ArticleIdList": ["10.1016/j.jhep.2018.10.040", "PMC6380944", "30414862"]}, {"Citation": "Ishfaq M, Pham T, Beaman C, et al. BTK inhibition reverses MDSC-mediated immunosuppression and enhances response to Anti-PDL1 therapy in neuroblastoma. Cancers. 2021;13(4):817. doi: 10.3390/cancers13040817.", "ArticleIdList": ["10.3390/cancers13040817", "PMC7919651", "33669187"]}, {"Citation": "Luo H, Vong CT, Chen H, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48. doi: 10.1186/s13020-019-0270-9.", "ArticleIdList": ["10.1186/s13020-019-0270-9", "PMC6836491", "31719837"]}, {"Citation": "Huang MY, Zhang LL, Ding J, et al. Anticancer drug discovery from Chinese medicinal herbs. Chin Med. 2018;13:35. doi: 10.1186/s13020-018-0192-y.", "ArticleIdList": ["10.1186/s13020-018-0192-y", "PMC6031194", "29997684"]}, {"Citation": "Huang M, Lu JJ, Ding J. Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect. 2021;11(1):5\u201313. doi: 10.1007/s13659-020-00293-7.", "ArticleIdList": ["10.1007/s13659-020-00293-7", "PMC7933288", "33389713"]}, {"Citation": "Chen F, Li J, Wang H, et al. Anti-tumor effects of chinese medicine compounds by regulating immune cells in microenvironment. Front Oncol. 2021;11:746917. doi: 10.3389/fonc.2021.746917.", "ArticleIdList": ["10.3389/fonc.2021.746917", "PMC8551633", "34722304"]}, {"Citation": "Mao D, Feng L, Gong H. The antitumor and immunomodulatory effect of yanghe decoction in breast cancer is related to the modulation of the JAK/STAT signaling pathway. Evid Based Complement Alternat Med. 2018;2018:8460526.", "ArticleIdList": ["PMC6276440", "30581487"]}, {"Citation": "Tian S, Song X, Wang Y, et al. Chinese herbal medicine Baoyuan Jiedu decoction inhibits the accumulation of myeloid derived suppressor cells in pre-metastatic niche of lung via TGF-beta/CCL9 pathway. Biomed Pharmacother. 2020;129:110380. doi: 10.1016/j.biopha.2020.110380.", "ArticleIdList": ["10.1016/j.biopha.2020.110380", "32554250"]}, {"Citation": "Xu ZH, Zhu YZ, Su L, et al. Ze-Qi-Tang formula induces granulocytic myeloid-derived suppressor cell apoptosis via STAT3/S100A9/Bcl-2/Caspase-3 Signaling to prolong the survival of mice with orthotopic lung cancer. Mediators Inflamm. 2021;2021:8856326.", "ArticleIdList": ["PMC8035014", "33867859"]}, {"Citation": "Ye Y, Fang Y, Xu W, et al. 3,3\u2019-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy. Biochem Pharmacol. 2016;115:77\u201384. doi: 10.1016/j.bcp.2016.06.018.", "ArticleIdList": ["10.1016/j.bcp.2016.06.018", "27372603"]}, {"Citation": "Jeon EJ, Davaatseren M, Hwang JT, et al. Effect of oral administration of 3,3\u2019-diindolylmethane on dextran sodium sulfate-induced acute colitis in mice. J Agric Food Chem. 2016;64(41):7702\u20139. doi: 10.1021/acs.jafc.6b02604.", "ArticleIdList": ["10.1021/acs.jafc.6b02604", "27700072"]}, {"Citation": "Huang Z, Jiang Y, Yang Y, et al. 3,3\u2019-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction. Mol Immunol. 2013;53(4):335\u201344. doi: 10.1016/j.molimm.2012.09.007.", "ArticleIdList": ["10.1016/j.molimm.2012.09.007", "23085552"]}, {"Citation": "Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21(2):201\u201330. doi: 10.1023/B:PHAM.0000016235.32639.23.", "ArticleIdList": ["10.1023/B:PHAM.0000016235.32639.23", "15032302"]}, {"Citation": "Zhang Z, Gao Z, Hu W, et al. 3,3\u2019-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Br J Pharmacol. 2013;170(3):649\u201360. doi: 10.1111/bph.12323.", "ArticleIdList": ["10.1111/bph.12323", "PMC3792002", "23902531"]}, {"Citation": "Li L, Zhang J, Diao W, et al. MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells. J Immunol. 2014;192(3):1034\u201343. doi: 10.4049/jimmunol.1301309.", "ArticleIdList": ["10.4049/jimmunol.1301309", "24391219"]}, {"Citation": "Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350\u20135. doi: 10.1126/science.aar4060.", "ArticleIdList": ["10.1126/science.aar4060", "PMC7391259", "29567705"]}, {"Citation": "Sehrawat A, Roy R, Pore SK, et al. Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants. Semin Cancer Biol. 2017;47:147\u201353. doi: 10.1016/j.semcancer.2016.11.009.", "ArticleIdList": ["10.1016/j.semcancer.2016.11.009", "PMC5435556", "27867044"]}, {"Citation": "Connolly EL, Sim M, Travica N, et al. Glucosinolates from cruciferous vegetables and their potential role in chronic disease: investigating the preclinical and clinical evidence. Front Pharmacol. 2021;12:767975. doi: 10.3389/fphar.2021.767975.", "ArticleIdList": ["10.3389/fphar.2021.767975", "PMC8575925", "34764875"]}, {"Citation": "Burnett JP, Lim G, Li Y, et al. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells. Cancer Lett. 2017;394:52\u201364. doi: 10.1016/j.canlet.2017.02.023.", "ArticleIdList": ["10.1016/j.canlet.2017.02.023", "PMC8892390", "28254410"]}, {"Citation": "Abbaoui B, Lucas CR, Riedl KM, et al. Cruciferous vegetables, isothiocyanates, and bladder cancer prevention. Mol Nutr Food Res. 2018;62(18):e1800079. doi: 10.1002/mnfr.201800079.", "ArticleIdList": ["10.1002/mnfr.201800079", "PMC6196731", "30079608"]}, {"Citation": "Heo JR, Lee GA, Kim GS, et al. Phytochemical-induced reactive oxygen species and endoplasmic reticulum stress-mediated apoptosis and differentiation in malignant melanoma cells. Phytomedicine. 2018;39:100\u201310. doi: 10.1016/j.phymed.2017.12.006.", "ArticleIdList": ["10.1016/j.phymed.2017.12.006", "29433671"]}, {"Citation": "Zhang X, Sukamporn P, Zhang S, et al. 3,3\u2019-diindolylmethane downregulates cyclin D1 through triggering endoplasmic reticulum stress in colorectal cancer cells. Oncol Rep. 2017;38(1):569\u201374. doi: 10.3892/or.2017.5693.", "ArticleIdList": ["10.3892/or.2017.5693", "28586058"]}, {"Citation": "Shin JH, Zhang L, Murillo-Sauca O, et al. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 2013;110(30):12391\u20136. doi: 10.1073/pnas.1302856110.", "ArticleIdList": ["10.1073/pnas.1302856110", "PMC3725066", "23836658"]}, {"Citation": "Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol Res. 2017;5(1):3\u20138. doi: 10.1158/2326-6066.CIR-16-0297.", "ArticleIdList": ["10.1158/2326-6066.CIR-16-0297", "PMC5426480", "28052991"]}, {"Citation": "Zhao Y, Wu TT, Shao S, et al. Phenotype, development, and biological function of myeloid-derived suppressor cells. Oncoimmunology. 2016;5(2):e1004983. doi: 10.1080/2162402X.2015.1004983.", "ArticleIdList": ["10.1080/2162402X.2015.1004983", "PMC4801459", "27057424"]}, {"Citation": "Marigo I, Dolcetti L, Serafini P, et al. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev. 2008;222:162\u201379. doi: 10.1111/j.1600-065X.2008.00602.x.", "ArticleIdList": ["10.1111/j.1600-065X.2008.00602.x", "18364001"]}, {"Citation": "Kim K, Skora AD, Li ZB, et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. P Natl Acad Sci USA. 2014;111(32):11774\u20139. doi: 10.1073/pnas.1410626111.", "ArticleIdList": ["10.1073/pnas.1410626111", "PMC4136565", "25071169"]}, {"Citation": "Strauss L, Mahmoud MAA, Weaver JD, et al. Targeted deletion of PD-1 in myeloid cells induces antitumor immunity. Sci Immunol. 2020;5(43):eaay1863. doi: 10.1126/sciimmunol.aay1863.", "ArticleIdList": ["10.1126/sciimmunol.aay1863", "PMC7183328", "31901074"]}, {"Citation": "Chen J, Sun HW, Yang YY, et al. Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer. Signal Transduct Target Ther. 2021;6(1):4. doi: 10.1038/s41392-020-00377-3.", "ArticleIdList": ["10.1038/s41392-020-00377-3", "PMC7791142", "33414378"]}, {"Citation": "Guo X, Qiu W, Liu Q, et al. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways. Oncogene. 2018;37(31):4239\u201359. doi: 10.1038/s41388-018-0261-9.", "ArticleIdList": ["10.1038/s41388-018-0261-9", "29713056"]}, {"Citation": "El Gazzar M. microRNAs as potential regulators of myeloid-derived suppressor cell expansion. Innate Immun. 2014;20(3):227\u201338. doi: 10.1177/1753425913489850.", "ArticleIdList": ["10.1177/1753425913489850", "PMC8639200", "23757323"]}, {"Citation": "Chung CD, Liao J, Liu B, et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 1997;278(5344):1803\u20135. doi: 10.1126/science.278.5344.1803.", "ArticleIdList": ["10.1126/science.278.5344.1803", "9388184"]}, {"Citation": "Sun S, Steinberg BM. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol. 2002;83(Pt 7):1651\u20138. doi: 10.1099/0022-1317-83-7-1651.", "ArticleIdList": ["10.1099/0022-1317-83-7-1651", "12075083"]}, {"Citation": "Jin Y. 3,3\u2019-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation. Mol Cell Biochem. 2011;358(1\u20132):345\u201354. doi: 10.1007/s11010-011-0985-0.", "ArticleIdList": ["10.1007/s11010-011-0985-0", "21761201"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "18"}, {"Year": "2022", "Month": "6", "Day": "18"}, {"Year": "2022", "Month": "6", "Day": "30", "Hour": "23", "Minute": "46"}, {"Year": "2022", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["35773674", "PMC9245307", "10.1186/s13020-022-00638-z", "10.1186/s13020-022-00638-z"]}}], "PubmedBookArticle": []}